A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Status:
Recruiting
Trial end date:
2025-01-31
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine the safety and efficacy of LY3556050 versus
placebo in participants with diabetic peripheral neuropathic pain (DPNP). The study will
lasts approximately 24 weeks, across 3 study periods.